0.7183
price down icon0.24%   -0.0017
after-market After Hours: .72 0.0017 +0.24%
loading
Adicet Bio Inc stock is traded at $0.7183, with a volume of 225.34K. It is down -0.24% in the last 24 hours and up +15.45% over the past month. Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
See More
Previous Close:
$0.72
Open:
$0.7
24h Volume:
225.34K
Relative Volume:
0.43
Market Cap:
$59.41M
Revenue:
$38.70M
Net Income/Loss:
$-117.88M
P/E Ratio:
-0.4225
EPS:
-1.7
Net Cash Flow:
$-92.84M
1W Performance:
+3.56%
1M Performance:
+15.45%
6M Performance:
-36.43%
1Y Performance:
-51.47%
1-Day Range:
Value
$0.6998
$0.7183
1-Week Range:
Value
$0.635
$0.72
52-Week Range:
Value
$0.4471
$1.70

Adicet Bio Inc Stock (ACET) Company Profile

Name
Name
Adicet Bio Inc
Name
Phone
617-482-2333
Name
Address
131 DARTMOUTH STREET, BOSTON
Name
Employee
152
Name
Twitter
Name
Next Earnings Date
2024-12-06
Name
Latest SEC Filings
Name
ACET's Discussions on Twitter

Compare ACET with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ACET
Adicet Bio Inc
0.7183 57.37M 38.70M -117.88M -92.84M -1.70
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Adicet Bio Inc Stock (ACET) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-30-24 Resumed Guggenheim Buy
Sep-11-24 Downgrade H.C. Wainwright Buy → Neutral
Jun-27-23 Downgrade Guggenheim Buy → Neutral
Jun-27-23 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-01-23 Downgrade JP Morgan Overweight → Neutral
Sep-21-22 Initiated JP Morgan Overweight
Mar-31-22 Initiated SMBC Nikko Outperform
Mar-08-22 Initiated Truist Buy
Mar-04-22 Initiated Jefferies Buy
May-18-21 Initiated BTIG Research Buy
Apr-23-21 Initiated H.C. Wainwright Buy
Apr-14-21 Initiated Canaccord Genuity Buy
Apr-08-21 Initiated Guggenheim Buy
Nov-04-20 Initiated B. Riley Securities Buy
Oct-27-20 Initiated JMP Securities Mkt Outperform
Oct-16-20 Initiated Wedbush Outperform
View All

Adicet Bio Inc Stock (ACET) Latest News

pulisher
May 26, 2025

Adicet Bio’s SWOT analysis: gamma-delta T cell therapy stock faces pivotal year - Investing.com

May 26, 2025
pulisher
May 25, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Shares Sold by D. E. Shaw & Co. Inc. - Defense World

May 25, 2025
pulisher
May 24, 2025

Financial Comparison: Adicet Bio (NASDAQ:ACET) & Trevena (NASDAQ:TRVN) - Defense World

May 24, 2025
pulisher
May 21, 2025

Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference - Business Wire

May 21, 2025
pulisher
May 20, 2025

Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) Price Target at $7.50 - Defense World

May 20, 2025
pulisher
May 17, 2025

Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know - MSN

May 17, 2025
pulisher
May 16, 2025

Adicet Bio (NASDAQ:ACET) Coverage Initiated at StockNews.com - Defense World

May 16, 2025
pulisher
May 10, 2025

Wedbush Comments on Adicet Bio’s Q3 Earnings (NASDAQ:ACET) - Defense World

May 10, 2025
pulisher
May 09, 2025

What is Wedbush’s Estimate for Adicet Bio Q1 Earnings? - Defense World

May 09, 2025
pulisher
May 08, 2025

Adicet Bio Reports Q1 2025 Results and Updates - TipRanks

May 08, 2025
pulisher
May 07, 2025

Marshall Wace LLP Sells 104,894 Shares of Adicet Bio, Inc. (NASDAQ:ACET) - Defense World

May 07, 2025
pulisher
May 06, 2025

Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Bluefield Daily Telegraph

May 06, 2025
pulisher
May 06, 2025

ACET's Cash Reserves Expected to Sustain Operations Until Late 2 - GuruFocus

May 06, 2025
pulisher
May 05, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 05, 2025
pulisher
May 04, 2025

Reviewing Adicet Bio (NASDAQ:ACET) and HUTCHMED (NASDAQ:HCM) - Defense World

May 04, 2025
pulisher
May 02, 2025

Renaissance Technologies LLC Has $882,000 Holdings in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World

May 02, 2025
pulisher
May 01, 2025

Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Apr 30, 2025
pulisher
Apr 30, 2025

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - Yahoo Finance

Apr 30, 2025
pulisher
Apr 29, 2025

Adicet Bio (NASDAQ:ACET) Rating Increased to Hold at StockNews.com - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting - BioSpace

Apr 28, 2025
pulisher
Apr 28, 2025

Adicet Bio Announces Oral Presentation Highlighting Preclinical Adi-270 Data At The American Society Of Gene And Cell Therapy 28Th Annual Meeting - marketscreener.com

Apr 28, 2025
pulisher
Apr 27, 2025

We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate - Yahoo Finance

Apr 27, 2025
pulisher
Apr 22, 2025

JMP maintains Market Perform on Adicet Bio shares By Investing.com - Investing.com Canada

Apr 22, 2025
pulisher
Apr 21, 2025

JMP maintains Market Perform on Adicet Bio shares - Investing.com

Apr 21, 2025
pulisher
Apr 19, 2025

Adicet Bio (NASDAQ:ACET) Now Covered by StockNews.com - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

Adicet Bio appoints Michael Grissinger to its board By Investing.com - Investing.com Canada

Apr 17, 2025
pulisher
Apr 17, 2025

Adicet Bio Appoints Michael Grissinger to the Board of Directors - BioSpace

Apr 17, 2025
pulisher
Apr 17, 2025

Adicet Bio appoints Michael Grissinger to its board - Investing.com

Apr 17, 2025
pulisher
Apr 17, 2025

Adicet Bio Appoints Michael Grissinger to Board - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Adicet Bio Appoints Michael Grissinger To The Board Of Directors - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

Adicet Bio Strengthens Board with Ex-Johnson & Johnson VP: Strategic Move for Cell Therapy Pioneer - Stock Titan

Apr 17, 2025
pulisher
Apr 15, 2025

Neuroscientific to Acquire Leading Stem Cell Technology - Investing News Network

Apr 15, 2025
pulisher
Apr 13, 2025

Norges Bank Acquires Shares of 429,550 Adicet Bio, Inc. (NASDAQ:ACET) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Adicet Bio faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria

Apr 12, 2025
pulisher
Apr 11, 2025

Adicet Bio faces potential Nasdaq delisting over share price - Investing.com

Apr 11, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Purchases New Stake in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World

Apr 02, 2025

Adicet Bio Inc Stock (ACET) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Cap:     |  Volume (24h):